Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales
EBSEmergent BioSolutions(EBS) Zacks Investment Research·2024-03-08 02:36

Emergent BioSolutions (EBS) reported an adjusted loss of 77 cents per share in fourth-quarter 2023, wider than the Zacks Consensus Estimate of a loss of 33 cents. In the year-ago quarter, EBS reported adjusted earnings of 11 cents per share. Revenues in the quarter totaled 276.6million,down16276.6 million, down 16% from the prior-year period’s level. The reported figure outpaced the Zacks Consensus Estimate of 247.6 million. The company's shares lost almost 16% in after-market trading on Mar 6, likely due to the earnings mi ...